Skip to main content
DexCom Inc.
Healthcare · Medical Devices
Made on Aug 27, 2026
Price at call $90.07
6-month call Bear -12.3%
Target by Feb 2027 $79.00
Great value below $62.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -12.3% to $79.00
Predicted High $89.20 in 2 weeks
Predicted Low $79.00 at 6 months
Max Drawdown (predicted) -12.3%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 27, 2026 1:25 pm
Bear DXCM trends lower to $79.00 (-12.3% from $90.07) by Feb 2027. decay
ThesisDXCM trades well above composite fair value with cracking narrative on Abbott competition, but risk-on regime and low beta cushion near-term downside. Expect a gradual drift lower toward the deterministic baseline as sentiment erodes and value gravity asserts, without a violent break given consistent earnings beats.
Invalidated ifA decisive break above $95 on positive CGM share data or an Abbott stumble would invalidate; conversely a break below $78 accelerates the path.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $90.07 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 27, 2026 $90.07 at call The anchor — every point below is measured from this price and date.
2 weeks Sep 10, 2026 $82.32–$97.82 typical range · internal point $89.20 ±8.6% 6/10 Mild drift lower, risk-on regime cushions selling
What actually happened: closed $83.88 on Sep 9, 2026 = -6.9% vs the call (predicted -1.0%)  ·  direction MISS (called flat, was down)  ·  off by 5.9 pp  ·  accuracy 4/10  ·  typical range ±8.6%: inside the band  ·  S&P -1.2% over the same window — lagged it
1 month Sep 27, 2026 $78.83–$101.31 typical range · internal point $87.80 ±12.5% 6/10 Sentiment weakness continues, no catalyst to reverse
2 months Oct 27, 2026 $85.50 -5.1% 5/10 Competitive narrative pressure builds into Q3 print
3 months Nov 27, 2026 $83.00 -7.8% 5/10 Earnings beat likely but guide questioned on share loss
4 months Dec 27, 2026 $82.00 -9.0% 4/10 Year-end positioning, tax selling on winners
5 months Jan 27, 2027 $80.50 -10.6% 4/10 January reset, value gravity toward baseline
6 months Feb 27, 2027 $79.00 -12.3% 4/10 Convergence toward deterministic endpoint, fair value pull

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $81.01 (-10.1%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$90.07
Composite fair value$40.23
Signal-adjusted fair value$41.96
DCF fair value$29.00
Anchored-PE fair value$89.60
Buy-below (value lens)$62.00
Value net score-58
Value confidence6 / 10
Quality net score+65
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 49.1%  3m 43.2%  6m 41.4%  
Daily σ (realism noise)2.7%
Beta vs S&P 500 1m 1.07  3m 0.51  5m 0.51  
Trailing 6-month return21.1%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Aug 26, 2026 1d behind DXCM-20260826-010001-9388
ext-forensic-memo Aug 27, 2026 freshest ext-DXCM-20260827-084420-c52e
ext-lens-quality Aug 27, 2026 freshest ext-DXCM-20260827-084420-c52e
ext-lens-sentiment Aug 27, 2026 freshest ext-DXCM-20260827-084420-c52e
ext-lens-value Aug 27, 2026 freshest ext-DXCM-20260827-084420-c52e
scenario-valuation Aug 27, 2026 freshest DXCM-20260827-072525-5c87
valuation-synthesis Aug 27, 2026 freshest DXCM-20260827-072525-5c87

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 27, 2026 v0.6.0 Bear $90.07 $79.00 -12.3% Feb 2027 viewing
Aug 26, 2026 v0.6.0 Bear $88.96 $80.00 -10.1% Feb 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.